Cargando…

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^

Detalles Bibliográficos
Autores principales:	Bertrums, Eline J.M., Zwaan, C. Michel, Hasegawa, Daisuke, de Haas, Valerie, Reinhardt, Dirk N., Locatelli, Franco, de Moerloose, Barbara, Dworzak, Michael, Buijs, Arjan, Smisek, Petr, Kolenova, Alexandra, Pronk, Cornelis Jan, Klusmann, Jan-Henning, Carboné, Ana, Ferster, Alina, Antoniou, Evangelia, Meshinchi, Soheil, Raimondi, Susana C., Niemeyer, Charlotte M., Hasle, Henrik, van den Heuvel-Eibrink, Marry M., Goemans, Bianca F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883540/ https://www.ncbi.nlm.nih.gov/pubmed/34854279 http://dx.doi.org/10.3324/haematol.2021.279507

Ejemplares similares

T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS
por: Aalbers, A M, et al.
Publicado: (2014)

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial
por: Schweitzer, Jana, et al.
Publicado: (2015)

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
por: Rasche, Mareike, et al.
Publicado: (2018)

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
por: Rasche, Mareike, et al.
Publicado: (2021)

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS)
por: Komrokji, Rami S., et al.
Publicado: (2023)

Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium
por: White, Tara, et al.
Publicado: (2022)

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration
por: Hammer, Anne Sofie Borg, et al.
Publicado: (2022)

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
por: Rasche, Mareike, et al.
Publicado: (2021)

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia
por: Bertrums, Eline J. M., et al.
Publicado: (2023)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
por: Rasche, M, et al.
Publicado: (2017)

Outcome of ALL With ALL-BFM-95 Protocol in Nepal
por: Sharma Poudyal, Bishesh, et al.
Publicado: (2023)

Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
por: Komrokji, Rami S., et al.
Publicado: (2020)

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
por: Obulkasim, Askar, et al.
Publicado: (2017)

Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia—A prospective international multicenter trial on behalf of the BFM‐SG and the EBMT‐PDWP
por: Pichler, Herbert, et al.
Publicado: (2019)

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
por: Rizzari, Carmelo, et al.
Publicado: (2019)

Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
por: Bertrums, Eline J.M., et al.
Publicado: (2022)

Pediatric AML: From Biology to Clinical Management
por: de Rooij, Jasmijn D. E., et al.
Publicado: (2015)

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
por: Poyer, Fiona, et al.
Publicado: (2022)

Communication with and on Behalf of Patients
por: Cheatham, Melvin L.
Publicado: (2013)

Apology on behalf of the publisher
Publicado: (2016)

Response in Behalf of the Graduates
por: Ward, B. B.
Publicado: (1859)

Reply on Behalf of the Class
por: Lathrop, H. K.
Publicado: (1870)

The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
por: Dalle, Jean-Hugues, et al.
Publicado: (2020)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited
por: Obulkasim, Askar, et al.
Publicado: (2015)

The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii
por: Russo, Thomas A., et al.
Publicado: (2016)

The sensor kinase BfmS controls production of outer membrane vesicles in Acinetobacter baumannii
por: Kim, Se Yeon, et al.
Publicado: (2019)

PB1747: OUTCOME OF CHILDHOOD ALLTREATED WITH ALL BFM IC 2009 PROTOCOL
por: Çilsaat, Gizem, et al.
Publicado: (2023)

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia
por: Verboon, Lonneke J., et al.
Publicado: (2016)

On behalf of CERN's scientific community
Publicado: (1991)

On Behalf of European and Indian Lepers
por: Carleton, M. B.
Publicado: (1898)

Reply on Behalf of the Class of 1874
por: Mosher, Geo. H.
Publicado: (1874)

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009
por: Lehrnbecher, Thomas, et al.
Publicado: (2022)

The clinical and biological characteristics of NUP98-KDM5A pediatric acute myeloid leukemia
por: Noort, Sanne, et al.
Publicado: (2020)

Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view
por: Hasaart, K. A. L., et al.
Publicado: (2021)

Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR
por: Farrow, John M., et al.
Publicado: (2018)

Genome-Wide Mapping Reveals Complex Regulatory Activities of BfmR in Pseudomonas aeruginosa
por: Fan, Ke, et al.
Publicado: (2021)

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group
por: Benetton, Maddalena, et al.
Publicado: (2022)

Long‐term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC‐BFM 2002 trial
por: Kowalczyk, Jerzy R., et al.
Publicado: (2019)

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
por: Zheng, Wen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ni7v96i9fn4v947mkn8odqocmn